Seasonal Influenza Vaccination Resources for Health Professionals
On June 30, 2022, CDC announced that Director Rochelle P. Walensky adopted the Decision memo approving the ACIP vote for a preferential recommendation for the use of higher dose (including high dose and recombinant) or adjuvanted flu vaccines over standard-dose unadjuvanted flu vaccines for adults 65 years and older. CDC’s full recommendations for the use of flu vaccines during 2022-2023 will appear in a forthcoming Morbidity and Mortality Weekly Report. Edits to this page are also forthcoming. More information can be found online: CDC Director Adopts Preference for Specific Flu Vaccines for Seniors
- Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices — United States, 2021–22 Influenza Season
- TABLE: Influenza vaccines — United States, 2021–22 influenza season
- FIGURE: Influenza vaccine dosing algorithm for children aged 6 months through 8 years — Advisory Committee on Immunization Practices, United States, 2021–22 influenza seasons
- Recommendations regarding influenza vaccination of persons who report allergy to eggs
- Frequently Asked Influenza (Flu) Questions: 2021-2022 Season
- Administration of Flu Vaccines with Other Vaccines
- Interim Clinical Considerations for Use of COVID-19 Vaccines Currently Authorized in the United States
- Pink Book: Vaccine Administration
- You Call The Shots: Vaccinating Adolescents
- Vaccine Administration Training Module
- Intramuscular (IM) Injection: Sites – YouTube
- Subcutaneous (SC or Subcut) Injection: Sites – YouTube
- Dosage & Administration (Q&A)
- Large-Scale Influenza Vaccination Clinic Planning
- Vaccine Storage and Handling Guidelines and Recommendations
- Influenza Vaccine Availability Tracking System (IVATS) , a resource to enable healthcare providers to find influenza vaccine to purchase.
- Addressing Concerns Pregnant People Might Have about Influenza Vaccine Safety
- Seasonal Influenza Vaccine Effectiveness, 2005-2020
- Flu Vaccine Effectiveness (Q&A for Health Professionals)
- Vaccine Adverse Event Reporting System (VAERS), also available by telephone at 1–800–822–7967
- Preventive Steps
- How to Prevent Flu
- Healthcare Provider Toolkit
- Frequently Asked Influenza (Flu) Questions: 2021-2022 Season
- Key Facts about Seasonal Influenza (Q&A)
- Inactivated Flu Vaccine: Vaccination Information Statement (VIS)
- Live, Intranasal Flu Vaccine: Vaccination Information Statement (VIS)
- Make a Strong Flu Vaccine Recommendation
People with egg allergies can receive any licensed, recommended age-appropriate influenza vaccine (IIV4, RIV4, or LAIV4) that is otherwise appropriate. People who have a history of severe egg allergy (those who have had any symptom other than hives after exposure to egg) should be vaccinated in a medical setting, supervised by a health care provider who is able to recognize and manage severe allergic reactions. Two completely egg-free (ovalbumin-free) flu vaccine options are available: quadrivalent recombinant vaccine and quadrivalent cell-based vaccine.